or primary peritoneal cancer, who have previously been treated with between one and three prior systemic treatment regimens can be treated with ELAHERE. ELAHERE was evaluated in the pivotal SORAYA ...

GSK has had another setback in its oncology business, after the FDA asked it to restrict use of its PARP inhibitor Zejula in ovarian, fallopian tube, or primary peritoneal cancer to patients with ...

Simultaneously committed and indifferent? The moon’s connection to Uranus fosters an unusual relationship. Give the connection a chance! Your rapport could be fleeting. You may meet through a ...